12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

  • Predictive Oncology POAI shares rose 36.4% to $1.95 during Tuesday's after-market session. The company's market cap stands at $7.9 million.
  • Brainstorm Cell BCLI shares moved upwards by 18.25% to $0.45. The company's market cap stands at $30.5 million.
  • Telomir Pharmaceuticals TELO stock increased by 12.92% to $7.34. The market value of their outstanding shares is at $217.3 million.
  • NRX Pharmaceuticals NRXP stock increased by 11.24% to $2.87. The market value of their outstanding shares is at $30.1 million.
  • TransMedics Gr TMDX shares moved upwards by 11.02% to $104.51. The company's market cap stands at $3.4 billion. As per the press release, Q1 earnings came out today.
  • Akari Therapeutics AKTX shares moved upwards by 10.0% to $1.54. The market value of their outstanding shares is at $12.2 million.

Losers

  • Concord Medical Services CCM stock declined by 23.3% to $0.65 during Tuesday's after-market session. The company's market cap stands at $28.3 million.
  • CVRx CVRX shares declined by 16.19% to $13.0. The market value of their outstanding shares is at $280.7 million. As per the press release, Q1 earnings came out today.
  • Mereo BioPharma Group MREO stock declined by 8.53% to $2.79. The company's market cap stands at $391.3 million.
  • BiomX PHGE stock declined by 8.15% to $0.44. The market value of their outstanding shares is at $24.2 million.
  • 10x Genomics TXG stock fell 8.13% to $26.9. The market value of their outstanding shares is at $3.2 billion. The company's, Q1 earnings came out today.
  • Cyclacel Pharmaceuticals CYCC shares fell 7.08% to $1.97. The market value of their outstanding shares is at $2.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!